- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0015032

Vallark Pharma Private Limited
About Vallark Pharma Private Limited
Data last updated:
Vallark Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 19 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24303TG2019PTC136953. Its GSTIN is 36AAHCV1809N1ZX (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Krishna Vallakati and Vijaya Laxmi Ande.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.96 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹3.78 Lakh (net margin -192.7%) and EBITDA of -₹3.55 Lakh (EBITDA margin -181.4%). Revenue has declined at a compounded annual rate (CAGR) of 66% over three years and 23% over five years.
Vallark Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0015032).
Company details
Recognitions & Rankings of Vallark Pharma
Contact details
Vallark Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressPlot No. 56 1st Floor Phase V Navodaya House Building Society, Kapra Mandal Medchal Malkajgiri Dist, Hyderabad, Telangana, India – 501301
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Vallark Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vallark Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vallark Pharma Private Limited, buy the company report.
Financials of Vallark Pharma Private Limited
FY 2025 filings availableVallark Pharma Private Limited reported revenue of ₹1.96 Lakh (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 65% fall in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -181.4% | ||||
| Net Profit Margin | -192.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vallark Pharma Private Limited, buy the company report.
Board of directors of Vallark Pharma Private Limited
Vallark Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Krishna Vallakati | Director | 19 Nov 2019 | 6 Years 11 Months | Current |
| Vijaya Laxmi Ande | Director | 19 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Vallark Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RV Newvisions Healthcare Private Limited | ₹1.97 Lakh (FY 2020) | 693.0% | Pune, Maharashtra, India | |||
| Venkateshwara Aromatics Private Limited | ₹1.97 Lakh (FY 2025) | 74.0% | Pune, Maharashtra, India | |||
| Carya Chemicals & Fertilizers Private Limited | ₹1.97 Lakh (FY 2025) | -95.0% | New Delhi, Delhi, India | |||
| Achetpa (OPC) Private Limited | ₹1.97 Lakh (FY 2025) | 1181.0% | Imphalwest, Manipur, India | |||
| Trans Molecules Pharma Private Limited | ₹1.96 Lakh (FY 2018) | -48.0% | Mandi, Himachal Pradesh, India | |||
| Vallark Pharma Private Limitedthis company | ₹1.96 Lakh (FY 2025) | -₹3.78 Lakh | -192.7% | -65.0% | Hyderabad, Telangana, India | |
| Apiform Laboratories Private Limited | ₹1.96 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Vilohit Care Tek Solutions Private Limited | ₹1.96 Lakh (FY 2025) | Udupi, Karnataka, India | ||||
| Jivabio Mineral and Fertilizers Private Limited | ₹1.96 Lakh (FY 2022) | -50.0% | Ujjain, Madhya Pradesh, India | |||
| Amrete Healthcare (India) Private Limited | ₹1.96 Lakh (FY 2024) | 55719.0% | Mumbai, Maharashtra, India | |||
| Gajanand Herbal Private Limited | ₹1.96 Lakh (FY 2024) | 18.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of Vallark Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vallark Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vallark Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vallark Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCV1809N1ZX | Telangana | Active | 12 Dec 2019 |
To see the full GST registrations and return filing status of Vallark Pharma Private Limited, buy the company report.
Recent activity
Vallark Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ravi Krishna Vallakati was appointed as Director on 19 Nov 2019.
Frequently asked questions
Vallark Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 19 November 2019 (7+ years old) and is registered under CIN U24303TG2019PTC136953.
Vallark Pharma has 2 current directors:
- Ravi Krishna Vallakati - Director
- Vijaya Laxmi Ande - Director
The latest financial statements of Vallark Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Vallark Pharma is 36AAHCV1809N1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Vallark Pharma is U24303TG2019PTC136953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vallark Pharma was incorporated on 19 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Vallark Pharma by revenue are RV Newvisions Healthcare Private Limited, Venkateshwara Aromatics Private Limited, Carya Chemicals & Fertilizers Private Limited, Achetpa (OPC) Private Limited, Trans Molecules Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravi Krishna Vallakati was appointed as Director on 19 Nov 2019. Vijaya Laxmi Ande was appointed as Director on 19 Nov 2019.
Yes, Vallark Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0015032).
The registered office of Vallark Pharma is at Plot No. 56 1st Floor Phase V Navodaya House Building Society, Kapra Mandal Medchal Malkajgiri Dist, Hyderabad, Telangana, India – 501301.
Vallark Pharma operates in the food and beverages industry, in the artificial fibres segment.

